Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)

CNY 8.45

(0.24%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.34 Billion 2.42 Billion 2.28 Billion 2.16 Billion 1.9 Billion 1.92 Billion
Total Current Assets 1.21 Billion 1.19 Billion 1.06 Billion 1.02 Billion 757.03 Million 766.93 Million
Cash And Short Term Investments 956.54 Million 832.21 Million 547.52 Million 748.29 Million 502.04 Million 57.66 Million
Cash and Cash Equivalents 326.17 Million 274.71 Million 93.5 Million 114.19 Million 117.33 Million 22.96 Million
Short Term Investments 630.37 Million 557.5 Million 454.02 Million 634.1 Million 384.7 Million 34.7 Million
Net Receivables 178.35 Million 203.11 Million 367.8 Million 196.87 Million 148.84 Million 162.9 Million
Inventory 69.89 Million 149.59 Million 145.77 Million 81.66 Million 104.12 Million 97.35 Million
Other Current Assets 8.79 Million 10.41 Million 4.78 Million 706.49 Thousand 2.02 Million 449 Million
Total Non-Current Assets 1.13 Billion 1.22 Billion 1.22 Billion 1.13 Billion 1.15 Billion 1.16 Billion
Net PPE 970.93 Million 1.02 Billion 989.26 Million 990.47 Million 1.01 Billion 1.01 Billion
Good Will And Intangible Assets 82.91 Million 93.25 Million 96.7 Million 98.58 Million 97.01 Million 97.4 Million
Good Will 517.41 Thousand 8.76 Million 8.76 Million 8.76 Million 8.76 Million 8.76 Million
Intangible Assets 82.39 Million 84.49 Million 87.93 Million 89.82 Million 88.24 Million 88.64 Million
Long-Term Investments 68.3 Million -476.12 Million -338.79 Million -598.82 Million -352.73 Million 1.82 Million
Tax Assets 11.25 Million 9.73 Million 9.93 Million 9.37 Million 7.09 Million 5.42 Million
Other Non Current Assets 140.16 Thousand 578.52 Million 462.93 Million 636.58 Million 389.21 Million 40.1 Million
Other Assets 1.00 - 1.00 - - -
Total Liabilities 290.34 Million 321.17 Million 328.94 Million 349.92 Million 251.13 Million 323.11 Million
Total Current Liabilities 257.25 Million 285.12 Million 293.36 Million 310.23 Million 207.9 Million 274.75 Million
Account Payables 128.75 Million 162.77 Million 114.9 Million 97.57 Million 111.15 Million 142.36 Million
Tax Payables 7.83 Million 4.93 Million 5.49 Million 5.18 Million 8.78 Million 15.53 Million
Short Term Debt 47.3 Million 40.01 Million 20.38 Million 122.34 Million 3 Million 2 Million
Deferred Revenue 15.58 Million 11.76 Million 79.62 Million 66.12 Million 71.58 Million 15.53 Million
Other Current Liabilities 65.61 Million 70.57 Million 78.45 Million 24.18 Million 22.16 Million 114.85 Million
Total Non Current Liabilities 33.09 Million 36.04 Million 35.57 Million 39.68 Million 43.23 Million 48.35 Million
Long-Term Debt - - - - 1.00 -
Deferred Revenue Non Current 8.5 Million 11.3 Million 13.05 Million 14.2 Million 14.66 Million 16.49 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -8.5 Million 1.00 1.00 - - -
Other Liabilities 1.00 1.00 - 1.00 - -
Total Equity 2.04 Billion 2.1 Billion 1.95 Billion 1.81 Billion 1.65 Billion 1.6 Billion
Stock Holders Equity 1.98 Billion 2.01 Billion 1.86 Billion 1.75 Billion 1.61 Billion 1.57 Billion
Common Stock 294.68 Million 294.68 Million 294.68 Million 294.68 Million 294.68 Million 294.68 Million
Retained Earnings 812.68 Million 854.46 Million 728.15 Million 656.49 Million 603.78 Million 549.35 Million
Accumulated other comprehensive income 163.76 Million 155.44 Million 130.9 Million 119.81 Million 16.83 Million 54.91 Million
Common Stock Equity 1.98 Billion 2.01 Billion 1.86 Billion 1.75 Billion 1.61 Billion 1.57 Billion
Capital Lease Obligation - - - - - -
Total Investments 698.67 Million 81.37 Million 115.22 Million 35.27 Million 31.97 Million 34.7 Million
Total Debt 47.3 Million 40.01 Million 20.38 Million 122.34 Million 3 Million 2 Million
Net Debt -278.86 Million -234.7 Million -73.12 Million 8.15 Million -114.33 Million -20.96 Million

Balance Sheet Charts